Antibodies
Researchers hope to use antibodies from the animals to develop a treatment that would help people soon after infection with the virus
| 4 min read
Under the agreement, Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19
| 2 min read
Bio-Rad's blood-based immunoassay test can help clinicians identify if an individual has developed antibodies against SARS-CoV-2, the virus associated with COVID-19
| 1 min read
Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership
| 2 min read
Researchers are studying ways to prevent β-amyloid peptides from forming these dangerous plaques in order to halt development of Alzheimer's disease in the brain
| 4 min read
Bio-Rad offers a portfolio of recombinant, monoclonal anti-idiotypic antibodies and drug-target complex binders for the development of highly selective and sensitive assays
| 2 min read
With manufacturing support from Omega Diagnostics, the laboratory-based test aims to deliver up to 46,000 results per day
| 2 min read
CAR T-cell therapy and bispecific antibodies: Frontiers in cancer immunotherapy
| 1 min read
The use of therapeutic antibodies has shown promise as an effective cancer treatment strategy
| 1 min read
BSC is collecting blood samples from sick and recovered COVID-19 patients to assist in developing COVID-19 therapies, vaccines, and diagnostic biomarkers
| 2 min read
Funded by the Bill and Melinda Gates Foundation, CoVIC seeks to find therapeutic candidates for COVID-19 in just weeks
| 3 min read
Prototypes will be sent to world-leading labs in UK, Senegal, Spain, China, Malaysia, and Brazil for priority validation
| 3 min read
